BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26046000)

  • 1. Increased expression of iASPP correlates with poor prognosis in FIGO IA2-IIA cervical adenocarcinoma following a curative resection.
    Kong F; Shi X; Li H; Li P; Yu J; Li X; Chen J; Sun Y; Jia Y
    Am J Cancer Res; 2015; 5(3):1217-24. PubMed ID: 26046000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of iASPP correlates with poor prognosis and chemoresistance/radioresistance in FIGO Ib1-IIa squamous cell cervical cancer.
    Cao L; Huang Q; He J; Lu J; Xiong Y
    Cell Tissue Res; 2013 May; 352(2):361-9. PubMed ID: 23420450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Expression of Inhibitor of Apoptosis-stimulating Protein of p53 (iASPP) and Methyltransferase-like 3 (METTL3) Correlate with Poor Prognosis in FIGO Ib1-IIa Squamous Cell Cervical Cancer.
    Wu F; Zhang Y; Fang Y; Ma S; Zheng H; Liu K; Wang R
    J Cancer; 2020; 11(9):2382-2389. PubMed ID: 32201509
    [No Abstract]   [Full Text] [Related]  

  • 4. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.
    Zhang W; Hou T; Niu C; Song L; Zhang Y
    PLoS One; 2015; 10(12):e0144360. PubMed ID: 26709519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
    Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
    Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can laparoscopic radical hysterectomy be a standard surgical modality in stage IA2-IIA cervical cancer?
    Hong JH; Choi JS; Lee JH; Eom JM; Ko JH; Bae JW; Park SH
    Gynecol Oncol; 2012 Oct; 127(1):102-6. PubMed ID: 22683586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of laparoscopic radical hysterectomy for early cervical adenocarcinoma].
    Zhang YN; Li B; Wang YT; Liu SH
    Zhonghua Fu Chan Ke Za Zhi; 2020 Sep; 55(9):600-608. PubMed ID: 32957748
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of laparoscopic versus abdominal radical hysterectomy for FIGO stage IB and IIA cervical cancer with tumor diameter of 3 cm or greater.
    Kong TW; Chang SJ; Lee J; Paek J; Ryu HS
    Int J Gynecol Cancer; 2014 Feb; 24(2):280-8. PubMed ID: 24407571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
    Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
    Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of solitary lymph node metastasis in patients with stages IA2 to IIA cervical carcinoma.
    Dai YF; Xu M; Zhong LY; Xie XY; Liu ZD; Yan MX; Yi H; Lin DM
    J Int Med Res; 2018 Oct; 46(10):4082-4091. PubMed ID: 29963935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Parameters for Patients with Cervical Cancer FIGO Stages IA2-IIB: A Long-Term Follow-Up.
    Obrzut B; Semczuk A; Naróg M; Obrzut M; Król P
    Oncology; 2017; 93(2):106-114. PubMed ID: 28463843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
    Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
    Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of 132 cases of cervical adenosquamous carcinoma and cervical adenocarcinoma].
    Meng YH; Li S; Hu T; Ma D; Lu YP; Wang H
    Chin J Cancer; 2010 Jan; 29(1):15-9. PubMed ID: 20038304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of ASPP gene family and its relationship with survival of patients with non-small cell lung cancer].
    Su M; Gu Y; Su S; Lu B
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):268-72. PubMed ID: 24989912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
    Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
    Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
    Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.
    Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q
    Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.